These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 1524350)

  • 21. Liver function and hepatitis markers in carriers of hepatitis B virus in New Zealand.
    Hopkirk N; Moyes CD; Lucas CR
    N Z Med J; 2000 Apr; 113(1107):114-6. PubMed ID: 10834277
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evolution of HBeAg/anti-HBe status and its relationship to clinical and histological outcome in chronic HBV carriers in childhood.
    Sodeyama T; Kiyosawa K; Akahane Y; Tanaka E; Wada S; Oike Y; Nakamura M; Yoda H; Imai Y; Gibo Y
    Am J Gastroenterol; 1986 Apr; 81(4):239-45. PubMed ID: 3962948
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical impact and efficacy of lamivudine therapy in de novo hepatitis B infection after liver transplantation.
    Castells L; Vargas V; Rodríguez F; Allende H; Buti M; Sánchez-Avila JF; Jardí R; Margarit C; Pumarola T; Esteban R; Guardia J
    Liver Transpl; 2002 Oct; 8(10):892-900. PubMed ID: 12360430
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatitis B virus DNA in chronic HBsAg carriers: correlation with HBeAg/anti-HBe status, anti-HD and liver histology.
    Stroffolini T; Sagnelli E; Rapicetta M; Felaco FM; Filippini P; Annella T; Petruzziello A; Chionne P; Sarrecchia B; Piccinino F
    Hepatogastroenterology; 1992 Feb; 39(1):62-5. PubMed ID: 1568710
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evolution of hepatitis B virus liver disease after hepatic replacement. Practical and theoretical considerations.
    Demetris AJ; Todo S; Van Thiel DH; Fung JJ; Iwaki Y; Sysyn G; Ming W; Trager J; Starzl TE
    Am J Pathol; 1990 Sep; 137(3):667-76. PubMed ID: 2399936
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [De novo hepatitis B infection after liver transplantation--evidence for the need of active hepatitis B vaccination of liver transplantation candidates].
    Rambusch EG; Nashan B; Tillmann HL; Böker KH; Schlitt HJ; Maschek H; Raab R; Manns MP
    Z Gastroenterol; 1998 Dec; 36(12):1027-35. PubMed ID: 10025054
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Immunohistochemical study of hepatitis B and D virus antigens (HBsAg, HBcAg, HDAg) in chronic liver diseases].
    Horváth G; Stotz G; Schaff Z; Tolvaj G; Dávid K
    Orv Hetil; 1996 May; 137(21):1133-8. PubMed ID: 8757107
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of liver biopsy in the management of liver dysfunction after hematopoietic stem-cell transplantation in a hepatitis B virus-prevalent patient population.
    Ma SY; Au WY; Ng IO; Lie AK; Leung AY; Liang RH; Lau GK; Kwong YL
    Transplantation; 2003 Jul; 76(1):169-76. PubMed ID: 12865805
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human immunodeficiency virus infection does not alter serum transaminases and hepatitis B virus (HBV) DNA in homosexual patients with chronic HBV infection.
    Bonacini M; Govindarajan S; Redeker AG
    Am J Gastroenterol; 1991 May; 86(5):570-3. PubMed ID: 1674196
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Researches on viral hepatitis markers correlated with pathomorphological and clinical aspects in chronic hepatitis.
    Brehar-Cioflec D; Vajda A; Negrea DA; Străin R; Tudose N; Sporea I; Moldovan R; Chidioşan C; Chirileanu O; Gaiţă-Criveanu D
    Rom J Virol; 1995; 46(3-4):107-13. PubMed ID: 9179963
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantification of intrahepatic hepatitis B virus (HBV) DNA in patients with chronic HBV infection.
    Cacciola I; Pollicino T; Squadrito G; Cerenzia G; Villari D; de Franchis R; Santantonio T; Brancatelli S; Colucci G; Raimondo G
    Hepatology; 2000 Feb; 31(2):507-12. PubMed ID: 10655278
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Distribution of the antigen of hepatitis B virus in liver tissue in healthy carriers and in patients with chronic active and acute hepatitis].
    Garciá-Ruiz H; Sotto-Escobar A; Gra-Oramas B
    Rev Gastroenterol Mex; 1989; 54(2):87-90. PubMed ID: 2772481
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sero-clearance of hepatitis B surface antigen in chronic carriers does not necessarily imply a good prognosis.
    Huo TI; Wu JC; Lee PC; Chau GY; Lui WY; Tsay SH; Ting LT; Chang FY; Lee SD
    Hepatology; 1998 Jul; 28(1):231-6. PubMed ID: 9657117
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A prospective histologic and immunohistochemical study of the liver in blood donors who are asymptomatic chronic carriers of HBs antigens. Apropos of 34 cases].
    Ben Rejeb A; Khediri F; Ebdelli N; Bouali R; Ben Ahmed F
    Ann Gastroenterol Hepatol (Paris); 1994 Sep; 30(4):157-62. PubMed ID: 7979147
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term delta superinfection in hepatitis B surface antigen carriers and its relationship to the course of chronic hepatitis.
    Colombo M; Cambieri R; Rumi MG; Ronchi G; Del Ninno E; De Franchis R
    Gastroenterology; 1983 Aug; 85(2):235-9. PubMed ID: 6345255
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serologic markers of hepatitis B virus (HBV) and hepatitis D virus infection in carriers of hepatitis B surface antigen who are frequently exposed to HBV.
    Tassopoulos NC; Papaevangelou GJ; Roumeliotou-Karayiannis A; Sjogren MH; Engle R; Karpodini E; Purcell RH
    Hepatogastroenterology; 1986 Aug; 33(4):151-4. PubMed ID: 3758906
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Significance of hepatitis B viremia levels determined by a quantitative polymerase chain reaction assay in patients with hepatitis B e antigen-negative chronic hepatitis B virus infection.
    Manesis EK; Papatheodoridis GV; Sevastianos V; Cholongitas E; Papaioannou C; Hadziyannis SJ
    Am J Gastroenterol; 2003 Oct; 98(10):2261-7. PubMed ID: 14572577
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Follow-up of chronic hepatitis B carriers. Serological course and risk of reactivation].
    Bujanda L; García Bengoechea M; Cilla G; Gil I; yArenas JI
    Rev Esp Enferm Dig; 1996 May; 88(5):335-9. PubMed ID: 8764540
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The significance of HB antigenemy in apparently healthy persons in the clinic for liver diseases.
    Lesnicar J; Zaversnik H; Ferluga D; Krk C
    Acta Hepatogastroenterol (Stuttg); 1975 Oct; 22(5):297-304. PubMed ID: 1199669
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Prognosis of acute hepatitis B].
    Malacco E; Iacono G; Risso F
    Minerva Med; 1979 Feb; 70(8):575-81. PubMed ID: 431875
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.